Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience Market Cap : 22.36M for March 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Bio-Rad Laboratories, Inc. | 7.049B |
| Bruker Corp. | 4.990B |
| Azenta, Inc. | 963.15M |
| Bionano Genomics, Inc. | 11.30M |
| Avantor, Inc. | 5.194B |
Market Cap Related Metrics
| PS Ratio | 2.564 |
| PEG Ratio | -0.0111 |
| Price to Book Value | 16.08 |
| Price to Free Cash Flow | 45.61 |
| Price | 5.00 |
| Earnings Yield | -25.69% |
| PEGY Ratio | -0.0111 |
| Operating PE Ratio | 2219.46 |